| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4006395 | American Journal of Ophthalmology | 2006 | 8 Pages |
Abstract
The combination of PDT and intravitreal triamcinolone acetonide requires careful consideration as a treatment option for neovascular AMD. In our case series, this treatment combination did not prevent a considerable decrease in VA. The main benefit of this combination treatment was a low number of verteporfin treatments. Baseline VA was the main predictor of the final outcome.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Erdem MD, Noémi MD, Siamak MD, Barbara MD, Katharina MD, Andreas MD, Michael MD,